EPO and mood disorder: Understanding the complex relationship between EPO and GSK3β (and its pleiotropic regulatory role across its large genetic network) on cognitive functioning in depressed patients may help reveal new drug targets (both upstream and downstream), aid precision medicine, and ultimately reduce disability and mortality for mood disorders.